Ameritas Investment Partners, Inc. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$65,712
+12.5%
5,166
+24.5%
0.00%
+50.0%
Q2 2023$58,418
-8.9%
4,1490.0%0.00%
-33.3%
Q1 2023$64,102
+8.7%
4,149
+25.5%
0.00%
+50.0%
Q4 2022$58,994
-3.3%
3,3050.0%0.00%
-33.3%
Q3 2022$61,000
+41.9%
3,3050.0%0.00%
+50.0%
Q2 2022$43,000
+38.7%
3,3050.0%0.00%
+100.0%
Q1 2022$31,000
-3.1%
3,3050.0%0.00%0.0%
Q4 2021$32,000
-71.4%
3,3050.0%0.00%
-75.0%
Q3 2021$112,000
-7.4%
3,3050.0%0.00%0.0%
Q2 2021$121,000
-18.2%
3,3050.0%0.00%
-33.3%
Q1 2021$148,000
-21.7%
3,3050.0%0.01%
-33.3%
Q4 2020$189,000
+11.2%
3,3050.0%0.01%
+12.5%
Q3 2020$170,000
-13.7%
3,3050.0%0.01%
-11.1%
Q2 2020$197,000
+181.4%
3,305
+94.9%
0.01%
+125.0%
Q1 2020$70,000
-28.6%
1,696
+7.6%
0.00%0.0%
Q4 2019$98,000
+84.9%
1,5760.0%0.00%
+100.0%
Q3 2019$53,000
+82.8%
1,576
+23.6%
0.00%
+100.0%
Q2 2019$29,000
+81.2%
1,275
+82.1%
0.00%0.0%
Q1 2019$16,000
+6.7%
7000.0%0.00%0.0%
Q4 2018$15,000
-44.4%
7000.0%0.00%0.0%
Q3 2018$27,000
-3.6%
7000.0%0.00%0.0%
Q2 2018$28,000
+100.0%
7000.0%0.00%0.0%
Q1 2018$14,000
-12.5%
7000.0%0.00%0.0%
Q4 2017$16,0007000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders